BDBM285994 (+/-)-Methyl N-{2,10-dioxo-8-[(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)carbamoyl]-1,2,3,4,5,6,7,8,9,10-decahydro-1,9-benzodiazacyclododecin-13-yl}carbamate::US10081623, Example 7

SMILES COC(=O)Nc1ccc2c(NC(=O)CCCCCC(NC2=O)C(=O)NC2Cc3ccccc3NC2=O)c1

InChI Key InChIKey=BHMHMFPCDCKZDO-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 285994   

TargetCoagulation factor XI(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM285994(US10081623, Example 7 | (+/-)-Methyl N-{2,10-dioxo...)
Affinity DataKi:  708nMpH: 7.4Assay Description:The effectiveness of compounds of the present invention as inhibitors of the coagulation Factors XIa, VIIa, IXa, Xa, XIIa, plasma kallikrein or throm...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2019
Entry Details
Go to US Patent